Restricting coverage for innovative medicines threatens the care patients need most.
America spends over $130 billion a year on kidney disease, more than one-quarter of the entire Medicare budget.
Despite this, the US lags behind 24 other countries in saving lives, including France, Saudi Arabia, and Iran.
This is not just a failure of policy, but a moral and economic failure.
In Arizona, an estimated 16,300 people are living with Chronic Kidney Disease (CKD), with Hispanic patients, especially women, being among the hardest hit.
Author's summary: Arizona kidney patients need access to innovative cures.